251 related articles for article (PubMed ID: 12057669)
41. Substituted 4-methylquinolines as a new class of anti-tuberculosis agents.
Jain R; Vaitilingam B; Nayyar A; Palde PB
Bioorg Med Chem Lett; 2003 Mar; 13(6):1051-4. PubMed ID: 12643909
[TBL] [Abstract][Full Text] [Related]
42. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.
Hans RH; Guantai EM; Lategan C; Smith PJ; Wan B; Franzblau SG; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2010 Feb; 20(3):942-4. PubMed ID: 20045640
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, antiviral, antituberculostic and antibacterial activities of some novel, 4-(4'-substituted phenyl)-6-(4"-hydroxyphenyl)-2-(substituted imino) pyrimidines.
Siddiqui AA; Rajesh R; Mojahid-Ul-Islam ; Alagarsamy V; Meyyanathan SN; Kumar BP; Suresh B
Acta Pol Pharm; 2007; 64(1):17-26. PubMed ID: 17665846
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
Ali MA; Shaharyar M; Siddiqui AA
Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
[TBL] [Abstract][Full Text] [Related]
46. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety.
Castaño LF; Quiroga J; Abonia R; Insuasty D; Vidal OM; Seña R; Rubio V; Puerto G; Nogueras M; Cobo J; Guzman J; Insuasty A; Insuasty B
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293443
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV
Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232
[TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis.
Surineni G; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues.
Nagesh HN; Suresh N; Mahalakshmi Naidu K; Arun B; Padma Sridevi J; Sriram D; Yogeeswari P; Chandra Sekhar KV
Eur J Med Chem; 2014 Mar; 74():333-9. PubMed ID: 24486416
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
Alegaon SG; Alagawadi KR; Dadwe DH
Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
[TBL] [Abstract][Full Text] [Related]
54. Antimycobacterial activity: a facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines.
Wei AC; Ali MA; Yoon YK; Ismail R; Choon TS; Kumar RS; Arumugam N; Almansour AI; Osman H
Bioorg Med Chem Lett; 2012 Aug; 22(15):4930-3. PubMed ID: 22749825
[TBL] [Abstract][Full Text] [Related]
55. Antitubercular agents. Part 2: new thiolactomycin analogues active against Mycobacterium tuberculosis.
Kamal A; Shaik AA; Sinha R; Yadav JS; Arora SK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1927-9. PubMed ID: 15780635
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, and biological evaluation of 4-(5-nitrofuran-2-yl)prop-2-en-1-one derivatives as potent antitubercular agents.
Tawari NR; Bairwa R; Ray MK; Rajan MG; Degani MS
Bioorg Med Chem Lett; 2010 Nov; 20(21):6175-8. PubMed ID: 20850299
[TBL] [Abstract][Full Text] [Related]
57. A Promising Drug Candidate as Potent Therapeutic Approach for Neuroinflammation and Its In Silico Justification of Chalcone Congeners: a Comprehensive Review.
Karati D; Mukherjee S; Roy S
Mol Neurobiol; 2024 Apr; 61(4):1873-1891. PubMed ID: 37801205
[TBL] [Abstract][Full Text] [Related]
58. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
[TBL] [Abstract][Full Text] [Related]
59. Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach.
Ventura TL; Calixto SD; de Azevedo Abrahim-Vieira B; de Souza AM; Mello MV; Rodrigues CR; Soter de Mariz e Miranda L; Alves de Souza RO; Leal IC; Lasunskaia EB; Muzitano MF
Molecules; 2015 May; 20(5):8072-93. PubMed ID: 25951004
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Lim SS; Jung SH; Ji J; Shin KH; Keum SR
J Pharm Pharmacol; 2001 May; 53(5):653-68. PubMed ID: 11370705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
